Targeting Disease Mechanisms
The discussion dives into the intricate process of selecting drug targets for diseases like IPF, emphasizing the importance of identifying consistently high-scoring targets across diverse patient populations. Insights reveal the challenges faced in biological AI, particularly the need for accessible biological targets and druggable candidates. A novel transformer model, precious one GPT, is highlighted for its role in prioritizing age-associated disease targets.In this clip
From this podcast
Eye on AI
Can Artificial Intelligence Extend Lifespan? | Alex Zhavoronkov
Related Questions